Ultrasound Diagnosis of Antibiotic Associated Diarrhea

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2008 by Shaare Zedek Medical Center.
Recruitment status was  Not yet recruiting
Information provided by:
Shaare Zedek Medical Center
ClinicalTrials.gov Identifier:
First received: April 8, 2008
Last updated: April 11, 2008
Last verified: April 2008

The hypothesis is that there are unique sonographic characteristics of antibiotic-associated diarrhea. We will compare the ultrasound findings in patients who received antibiotics and developed diarrhea to toxin analysis for clostridium difficile in stool in order to find differences in the sonographic findings in the positive and negative cases.

Antibiotic-Associated Diarrhea

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective

Resource links provided by NLM:

Further study details as provided by Shaare Zedek Medical Center:

Estimated Enrollment: 100
Study Start Date: April 2008
Estimated Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients in internal and geriatrics departments who developed diarrhea in a period of 72 hours since the beginning of admission and received antibiotics.


Inclusion Criteria:

  • admitted patients who developed diarrhea in 72 hours since the beginning of admission
  • patients age above 18 years.
  • patients received antibiotics during admission

Exclusion Criteria:

  • other reasons of diarrhea
  • drugs induced diarrhea
  • length of time since the beginning of diarrhea is shorter than 72 hours.
  • patients had diarrhea during the first day of admission
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00658151

Contact: Michael Avital, doctor 9727727340 avital99@hotmail.com
Contact: Yonit Veiner, doctor 9728687373 yonitw@zahav.net.il

Shaare Zedek Medical Center
Jerusalem, Israel
Sponsors and Collaborators
Shaare Zedek Medical Center
  More Information

No publications provided

Responsible Party: Radiologist, Shaare Zedek Medical Center
ClinicalTrials.gov Identifier: NCT00658151     History of Changes
Other Study ID Numbers: avital.ctil
Study First Received: April 8, 2008
Last Updated: April 11, 2008
Health Authority: Israel: Ministry of Health

Keywords provided by Shaare Zedek Medical Center:

Additional relevant MeSH terms:
Signs and Symptoms
Signs and Symptoms, Digestive

ClinicalTrials.gov processed this record on October 02, 2015